Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Long-term Outcome After Intravenous Thrombolysis of Basilar Artery Occlusion

21.10.2004


Occlusion of the basilar artery (BAO) is a relatively infrequent but the most catastrophic form of ischemic stroke with a dismal natural course, carrying from 85 to almost 95 % mortality. Complete BAO precipitates a sudden or gradually worsening clinical syndrome with bilateral motor weaknesses, visual or speech disturbances, deficits in motor coordination and balance, and often leads to reduced consciousness. The most devastating end-point is the locked-in state, in which the patient is conscious but can move only his or her eyes. Many stroke centers have in the past used invasive, intra-arterial thrombolysis to recanalize BAO, which is limited to hospitals with immediate invasive radiologist service.

Previous reports have advocated thrombolytics delivered with invasive endovascular approach to the occlusion site, but even a short delay in the onset of therapy has been reported to be the single most critical factor affecting outcome. Due to unacceptable treatment delays, Finnish neurologists led by Docent Perttu J. Lindsberg and Professor Markku Kaste at Helsinki University Central Hospital reverted from intra-arterial approach to noninvasive, intravenous delivery of alteplase, a protocol used more commonly in anterior circulation strokes. The results of this study were published 20.10.2004 in JAMA (Journal of American Medical Association).

Since 1995, 50 patients with proven BAO were treated in Helsinki according to institutional thrombolysis protocol. By 3 months, 20 patients (40%) died, while 12 patients (24%) reached independence in activities of daily life. On the long-term, patients with recanalized basilar artery and fair outcome continued to improve functionally and survivors reported unexpectedly satisfactory ratings of the quality of their daily life.



Rates of survival, recanalization and independent functional outcome are at least equally good than reported with endovascular invasive approaches, but the benefits of intravenous therapy are that it can start thrombolysis faster and can be used more widely than the invasive approaches.

Paivi Lehtinen | alfa
Further information:
http://www.helsinki.fi

More articles from Health and Medicine:

nachricht New flexible, transparent, wearable biopatch, improves cellular observation, drug delivery
12.11.2018 | Purdue University

nachricht Exosomes 'swarm' to protect against bacteria inhaled through the nose
12.11.2018 | Massachusetts Eye and Ear Infirmary

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

Im Focus: Nanorobots propel through the eye

Scientists developed specially coated nanometer-sized vehicles that can be actively moved through dense tissue like the vitreous of the eye. So far, the transport of nano-vehicles has only been demonstrated in model systems or biological fluids, but not in real tissue. The work was published in the journal Science Advances and constitutes one step further towards nanorobots becoming minimally-invasive tools for precisely delivering medicine to where it is needed.

Researchers of the “Micro, Nano and Molecular Systems” Lab at the Max Planck Institute for Intelligent Systems in Stuttgart, together with an international...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

In focus: Peptides, the “little brothers and sisters” of proteins

12.11.2018 | Life Sciences

Materials scientist creates fabric alternative to batteries for wearable devices

12.11.2018 | Materials Sciences

A two-atom quantum duet

12.11.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>